rs1554498506
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_002769.5(PRSS1):c.153C>T(p.Ser51Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_002769.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- hereditary chronic pancreatitisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Illumina, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002769.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PRSS1 | TSL:1 MANE Select | c.153C>T | p.Ser51Ser | synonymous | Exon 2 of 5 | ENSP00000308720.7 | P07477 | ||
| PRSS1 | TSL:5 | c.153C>T | p.Ser51Ser | synonymous | Exon 2 of 6 | ENSP00000417854.1 | E7EQ64 | ||
| PRSS1 | TSL:2 | c.153C>T | p.Ser51Ser | synonymous | Exon 2 of 5 | ENSP00000419912.2 | H0Y8D1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152198Hom.: 0 Cov.: 35
GnomAD4 exome Cov.: 67
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 152198Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 74354
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.